Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase-Reference-Cited by-同舟云学术

Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase

Published:2011-03-08 Issue:12 Volume:108 Page:5021-5026
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Garrett J. T.,Olivares M. G.,Rinehart C.,Granja-Ingram N. D.,Sanchez V.,Chakrabarty A.,Dave B.,Cook R. S.,Pao W.,McKinely E.,Manning H. C.,Chang J.,Arteaga C. L.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference24 articles.

1. The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy

2. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

3. Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein

4. ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase

Cited by 382 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER3 receptor and its role in the therapeutic management of metastatic breast cancer;Journal of Translational Medicine;2024-07-17

2. HER3 V104 mutations regulate cell signaling, growth, and drug sensitivity in cancer;Molecular Carcinogenesis;2024-05-15

3. HER3-targeted therapy: the mechanism of drug resistance and the development of anticancer drugs;Cancer Drug Resistance;2024-04-29

4. Artemisia argyi extracts overcome lapatinib resistance via enhancing TMPRSS2 activation in HER2‐positive breast cancer;Environmental Toxicology;2024-03-06

5. Overcoming brain-derived therapeutic resistance in HER2+ breast cancer brain metastasis;2024-02-22